INFLUENCE OF URSODEOXYCHOLIC ACID TREATMENT ON THE UK-PBC RISK SCORE IN PRIMARY BILIARY CHOLANGITIS

被引：0
|
作者：
Marenco-Flores, Ana
Sierra, Leandro
Kahan, Tamara F.
Barba, Romelia
Ferrigno, Bryan W.
Goyes, Daniela
Medina-Morales, John E.
Bonder, Alan
Patwardhan, Vilas
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1577
引用
收藏
页码：S1699 / S1699
页数：1
相关论文
共 50 条
  • [21] Clinician confidence in stratifying risk in primary biliary cirrhosis - a UK-PBC survey
    Corrigan, Margaret
    Vale, Luke
    Coughlan, Diarmuid
    Jones, David
    Hirschfield, Gideon
    HEPATOLOGY, 2015, 62 : 526A - 526A
  • [22] Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid
    van Hooff, M. C.
    Werner, E.
    van der Meer, A. J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 14 - 21
  • [23] Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC
    Liu, Benjamin D.
    Qureshi, Kamran
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 346 - 348
  • [24] Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC
    Benjamin D. Liu
    Kamran Qureshi
    Digestive Diseases and Sciences, 2023, 68 : 346 - 348
  • [25] Predicted risk of end stage liver disease utilizing the UK-PBC risk score with continued standard of care and subsequent addition of obeticholic acid for 60 months in patients with primary biliary cholangitis
    Jones, David
    Carbone, Marco
    Mells, George
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    MacConell, Leigh
    JOURNAL OF HEPATOLOGY, 2020, 73 : S196 - S196
  • [26] Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis
    Honda, Akira
    Tanaka, Atsushi
    Kaneko, Tetsuji
    Komori, Atsumasa
    Abe, Masanori
    Inao, Mie
    Namisaki, Tadashi
    Hashimoto, Naoaki
    Kawata, Kazuhito
    Takahashi, Atsushi
    Ninomiya, Masashi
    Kang, Jong-Hon
    Arakawa, Mie
    Yamagiwa, Satoshi
    Joshita, Satoru
    Umemura, Takeji
    Sato, Ken
    Kaneko, Akira
    Kikuchi, Kentaro
    Itakura, Jun
    Nomura, Takako
    Kakisaka, Keisuke
    Fujii, Hideki
    Kawada, Norifumi
    Takikawa, Yasuhiro
    Masaki, Tsutomu
    Ohira, Hiromasa
    Mochida, Satoshi
    Yoshiji, Hitoshi
    Iimuro, Satoshi
    Matsuzaki, Yasushi
    Takikawa, Hajime
    HEPATOLOGY, 2019, 70 (06) : 2035 - 2046
  • [27] Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis
    Honda, Akira
    Tanaka, Atsushi
    Komori, Atsumasa
    Abe, Masanori
    Inao, Mie
    Mochida, Satoshi
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    Hashimoto, Naoaki
    Kawata, Kazuhito
    Takahashi, Atsushi
    Ohira, Hiromasa
    Kang, Jong-Hon
    Yamagiwa, Satoshi
    Joshita, Satoru
    Umemura, Takeji
    Sato, Ken
    Itakura, Jun
    Kaneko, Akira
    Kakisaka, Keisuke
    Takikawa, Yasuhiro
    Kikuchi, Kentaro
    Takikawa, Hajime
    Matsuzaki, Yasushi
    HEPATOLOGY, 2017, 66 : 42A - 43A
  • [28] LONG TERM TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH URSODEOXYCHOLIC ACID (UDCA) - IDENTIFYING PREDICTORS OF RESPONSE.
    Haddadin, Yazan
    Hashim, Ahmed
    Vickers, Laura
    Jamil, Khaleel M.
    GASTROENTEROLOGY, 2019, 156 (06) : S348 - S348
  • [29] Hospitalisation for primary biliary cirrhosis: a UK-PBC analysis of hospital episodes
    Hirschfield, Gideon
    Vale, Luke
    Mayne, Tracy J.
    Mells, George F.
    Shapiro, David
    Jones, David
    HEPATOLOGY, 2015, 62 : 921A - 921A
  • [30] THE IMPACT OF LIVER TRANSPLANTATION ON THE PHENOTYPE OF PRIMARY BILIARY CIRRHOSIS (PBC) IN THE UK-PBC COHORT
    Mells, G.
    Carbone, M.
    Pells, G.
    Newton, J.
    Bathgate, A.
    Burroughs, A.
    Heneghan, M.
    Neuberger, J.
    Day, D.
    Ducker, S.
    Sandford, R.
    Alexander, G.
    Jones, D.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S392 - S392
12345